{"id":"W4396590704","doi":"10.1158/1538-7445.sabcs23-po1-20-13","title":"Abstract PO1-20-13: TROPION-Breast04: A phase 3 study of neoadjuvant datopotamab deruxtecan (Dato-DXd) + durvalumab followed by adjuvant durvalumab vs the standard of care in treatment-naive early-stage triple negative or HR-low/HER2– breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Durvalumab; Medicine; Stage (stratigraphy); Adjuvant; Standard of care; Internal medicine; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001629859,0.001445522,0.001578423,0.0003738535,0.0003639837,0.00130452,0.0010995,0.001274835,0.00710809],"category_scores_gemma":[0.0006078502,0.0005789503,0.001150504,0.0003928699,0.0009535836,0.0009429802,0.0003189535,0.004473869,0.001783406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009400057,"about_ca_system_score_gemma":0.001657197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001054317,"about_ca_topic_score_gemma":0.003080117,"domain_scores_codex":[0.9996927,0.0001339843,0.00001423141,0.00005375499,0.00003300741,0.0000723892],"domain_scores_gemma":[0.9995222,0.0000653959,0.0000663392,0.00003904737,0.00003639556,0.0002706204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6777609,0.1461542,0.002805971,0.001096489,0.001322365,0.0002041202,0.0002182741,0.002069099,0.06828496,0.0004951655,0.006662652,0.09292579],"study_design_scores_gemma":[0.4790351,0.5067215,0.004311576,0.00005392309,0.0005015318,0.0001949071,0.00006517324,0.001135243,0.005023448,0.0002308691,0.002695447,0.00003127923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881833,0.002798001,0.0006173512,0.0007391581,0.0002629429,0.002560958,0.001650252,0.0001605677,0.003027644],"genre_scores_gemma":[0.9805501,0.002916318,0.001878368,0.001420991,0.0002201223,0.002836447,0.003444977,0.00006738462,0.006665339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00710809,"threshold_uncertainty_score":0.02377892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02952137439804262,"score_gpt":0.3900360376195528,"score_spread":0.3605146632215102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}